Skip to content
The Nexus
DossierENTITY

Senate Bill 751

Coverage of Senate Bill 751 in the Nexus archive.

Earliest in view: Jul 1 · 18:29 UTCMost recent: Jul 1 · 18:29 UTC
Co-mentioned in this coverage
Novartis Pharmaceuticalsorganization1Missouriplace1340B programtopic1Eighth Circuitorganization1Ralph R. Ericksonperson1M. Douglas Harpoolperson1
Recent coverage
  • HEALTHJul 1 · 18:29 UTCCOURTHOUSE NEWS
    Novartis stumbles in challenge to Missouri discounted drug mandate

    An Eighth Circuit panel denied Novartis Pharmaceuticals' request to block Missouri's Senate Bill 751, which requires drugmakers to provide discounted 340B program drugs to eligible providers. The court ruled the law does not violate the dormant commerce clause as it regulates only in-state delivery of drugs to contract pharmacies.